← FDA Drug Approvals (Drugs@FDA)

PREGABALIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RENATA · Approved 2019-12-26

Drug application

FDA Application #

ANDA210585

Application type

Abbreviated New Drug Application (Generic)

Brand name

PREGABALIN

Generic name

Pregabalin

Active ingredients

PREGABALIN

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

RENATA

First approval

2019-12-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown